Shelly K. Sapp, MS

Article Type

Article

Changed

Wed, 02/13/2019 - 15:55

Display Headline

Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

Author(s)

Matthew T. Roe, MD

Shelly K. Sapp, MS

A. Michael Lincoff, MD

Article PDF

ccjm67_2-0131.pdf

Author and Disclosure Information

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; lincofa@ccf.org

Issue

Cleveland Clinic Journal of Medicine - 67(2)

Publications

Cleveland Clinic Journal of Medicine

Topics

Page Number

131-140

Read more about Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

Sections

Reviews

Author(s)

Matthew T. Roe, MD

Shelly K. Sapp, MS

A. Michael Lincoff, MD

Author(s)

Matthew T. Roe, MD

Shelly K. Sapp, MS

A. Michael Lincoff, MD

Author and Disclosure Information

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; lincofa@ccf.org

Author and Disclosure Information

Matthew T. Roe, MD
Division of Cardiology, Duke Clinical Research Institute

Shelly K. Sapp, MS
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center

A. Michael Lincoff, MD
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic; Editor of Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Diseases

Address: A. Michael Lincoff, MD, Department of Cardiology, Desk F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; lincofa@ccf.org

Article PDF

ccjm67_2-0131.pdf

Article PDF

ccjm67_2-0131.pdf

Issue

Cleveland Clinic Journal of Medicine - 67(2)

Issue

Cleveland Clinic Journal of Medicine - 67(2)

Page Number

131-140

Page Number